Form 13-F position report

OBSIDIAN THERAPEUTICS INC COM

Reported by Kalehua Capital Management LLC

OBX CUSIP 67448A106 Manager CIK 0002106181

First reported at 416,649 shares this quarter.

New
% of reported 13F value 4.32% This manager · Q3 2026
Shares 416,649 Quarter-end amount reported
Reported value $5,720,591 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 5720591

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for OBSIDIAN THERAPEUTICS INC COM held by Kalehua Capital Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 416,649 +416,649 (0.0%) 4.32% $5,720,591 2026-11-13

Who else reported the position

60 managers reported OBSIDIAN THERAPEUTICS INC COM for Q3 2026.

Managers reporting OBSIDIAN THERAPEUTICS INC COM in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RA CAPITAL MANAGEMENT L P New 5,957,103 +5,957,103 0.82% $81,791,024 1 qtr
Atlas Venture Life Science Advisors LLC New 4,503,149 +4,503,149 9.8% $61,828,236 1 qtr
Paradigm Biocapital Advisors LP New 4,155,214 +4,155,214 1.13% $57,051,088 1 qtr
Novo Holdings A S New 3,123,992 +3,123,992 2.88% $42,892,410 1 qtr
Trails Edge Capital Partners LP New 2,495,660 +2,495,660 4.92% $34,265,412 1 qtr
VANGUARD CAPITAL MANAGEMENT LLC New 2,441,332 +2,441,332 < 0.01% $33,519,488 1 qtr
Octagon Capital Advisors LP New 2,414,610 +2,414,610 4.42% $33,152,595 1 qtr
TCG Crossover Management LLC New 2,196,138 +2,196,138 0.85% $30,152,975 1 qtr
Deep Track Capital LP New 2,120,050 +2,120,050 0.47% $29,108,287 1 qtr
CITADEL ADVISORS LLC New 1,947,843 +1,947,843 < 0.01% $26,743,884 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
416,649
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.